Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Company Announcement No. 19, 2022 – Addendum to Nordea Kredits final terms

The following security codes have been added to the final terms of fixed rate callable covered mortgage bonds (SDRO): Callable fixed-rate annuity bond ISIN code Nom Name        Opening Closing Maturity Currency interest date date date rate/ Maturity DK0002053545 2.0% 2.0NDASDRO43 17/02 31/08 01/10 DKK          2043 -2022 -2023 -2043     DK0002053461 2.5% 2.5NDASDRO53 17/02 31/08 01/10 DKK          2053

DexTech Medical AB, Half-year report July 1 - December 31, 2021

Summary of the Second Quarter (2021-10-01 – 2021-12-31) · Net sales amounted to MSEK 0,0 (0,0) · Operating profit/loss amounted to MSEK -1,1 (-1,6) · Earnings per share* SEK -0.08 (-0.10) * Before dilution. Earnings per share: Profit for the period divided by the average number of shares 14,920,478. For the comparison period, the average number of shares was 14,920,478. Amounts in brackets refer to the corresponding period last year. Summary of the First Half-year (2021-07-01 – 2021-12-31) · Net sales amounted to MSEK 0,0 (0,0) · Operating profit/loss amounted to

Presentation of K-Fastigheter’s Year-end report 2021

K-Fast Holding AB (“K-Fastigheter”) publishes its Year-end report 2021 on 17 February 2022, before the opening of the stock market. The report will be presented in a pre-recorded audio cast at 10.00 a.m. CET the same day.Jacob Karlsson, CEO, and Martin Larsson, CFO, will present the earnings and operations. The presentation materials (slides + sound) will be available at www.k-fastigheter.com/en/investors/presentations. The presentation will be held in Swedish, with presentation materials in English.Questions may be addressed in writing to ir@k-fastigheter.se with answers being

Human olfactory mucosa cell model opens a new perspective on Alzheimer’s disease

Researchers at the University of Eastern Finland have developed and characterized a new cell model for Alzheimer’s disease that has wide utility for research and could prove useful in early diagnosis and testing of new therapies. In collaboration with clinicians at Kuopio University Hospital, the researchers collected nasal biopsies from cognitively healthy individuals and patients diagnosed with Alzheimer’s disease over several years. Following tissue processing, the researchers applied a powerful single cell RNA sequencing approach to characterize the patient-derived cells of the

Global UTM Association Kicks Off 2022 with New Strategic Direction

Brussels, 15 February 2022 - Amid new developments in technology, standards and global regulations has led the Global Uncrewed Traffic Management Association (GUTMA) to take a step forward and start 2022 by infusing the Association with a new strategic direction and mission statement. The Association comes up with a clear vision for the next five years, alongside creating new working groups and high-level assets for the industry. The Association will also hold an online conference on a competitive U-space services market on 15[th] March 2022.Bolstered by 60 global drone companies membership,

Q-Free: Mandatory notification of trade

(Oslo 15 February 2022) Geir Bjørlo, member of the Board of Directors of Q-Free ASA, has today bought 34,947 shares in Q-Free ASA, at an average price of NOK 7.38 per share. The shares were acquired through Illuminator AS, a company controlled by Bjørlo. Following the transaction, Bjørlo controls 152,093 shares in Q-Free ASA. The notification form is included in the attachment. This information is subject to disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.

Asetek Announces Exclusive Supply Agreement with Motor Manufacturer HangZhou MiGE

Hangzhou MiGE Electric to Produce Asetek Sim Racing Wheel Bases Combining Its Premium Motor Technology and Asetek Design and ElectronicsAalborg, Denmark – February 15, 2022 –– Asetek, sim racing gear innovator, the creator of the all-in-one liquid cooler, and the global leader in liquid cooling solutions for gaming PCs and DIY enthusiasts, today announced an exclusive supply agreement with HangZhou MiGE Electric Co., Ltd. (MiGE) for its high-end wheel bases for sim racing. MiGE will use its highly-effective servo motor technology to produce a full range of wheel bases exclusively for Asetek

BEWI - Updated information regarding extraordinary general meeting to be held on 16 February 2022

Reference is made to the stock exchange notice by BEWI ASA on 26 January 2022 regarding the notice of the extraordinary general meeting (EGM) to be held on 16 February 2022 at 11:00 CET at the offices of Advokatfirmaet Thommessen AS (Ruseløkkveien 38, 0251 Oslo). Due to the ongoing situation relating to the spread of the Covid-19 virus (especially the Omicron variant), the shareholders have been encouraged to abstain from appearing in person at the EGM, but instead to participate by following the meeting through Microsoft Teams. BEWI will provide guidance on how to attend the EGM

Pfizer’s announced purchase of Arena Pharmaceuticals exemplifies a satisfactory acquisition within the CBD medical treatment industry

CS MEDICA A/S (”CS MEDICA” or the ”Company”) see a strategic turnaround and new era for the CBD Medical treatment sector as Pfizer has announced the acquisition of Arena Pharmaceuticals. The acquisition exemplifies Big Pharma moving into the Cannabinoid treatment space and acknowledging Cannabinoids (CBD) in the medical treatment market.Pfizer’s announced[1] purchase of the US clinical-trial stage cannabinoids company, Arena Pharmaceuticals, exemplifies a satisfactory acquisition and a game-changer for CS MEDICA and the CBD medical treatment industry in which the Company operates. With this

Correction: HANZA’s Year-end report 2021: An expansive year with profitable growth

Correction regards the reference to the Market Abuse Regulation in the foot note of this press release HANZA Holding AB (publ), listed on Nasdaq Stockholm, today publishes its year-end report for 2021, which shows strong organic growth and increased profitability. Furthermore, the company carried out its largest expansion program to date with investments, acquisitions and activities aimed at developing the Group for continued growth.Fourth quarter 2021 · Net sales increased by 45 % to SEK 717 million (494). Operating profit (EBITA) increased to SEK 43.0 million (18.6), which

Neste’s renewable and circular solutions helped customers reduce greenhouse gas emissions globally by 10.9 million tons in 2021

Neste Corporation, Press Release, 15 February 2022 at 12 p.m. (EET)In 2021, Neste’s renewable and circular solutions helped customers reduce their greenhouse gas (GHG) emissions globally by 10.9 million tons* altogether. This amount equals the annual carbon footprint of 1.7 million average EU citizens (source: World Bank) or the removal of 4.2 million passenger cars from the roads for a full year.“With the 10.9 million tons reduction in GHG emissions, we are more than halfway to our commitment of helping our customers reduce emissions with our renewable and circular solutions by

ABS Appoints Stamatis Fradelos Vice President of Regulatory Affairs

Industry Veteran to Spearhead ABS Engagement with Global Maritime Administrations and Regulatory Bodies (ATHENS) As shipowners navigate an ever more complex regulatory environment, ABS has appointed specialist Stamatis Fradelos as Vice President of Regulatory Affairs. Fradelos, who returns to ABS’ Athens office, where he was previously Business Director and member of the IACS Environmental Panel, will spearhead ABS engagement with administrations and regulatory bodies and support the industry with compliance guidance. “ABS is engaged with maritime regulators and

First patient randomized in pivotal TRANSFORM study with setanaxib

Calliditas Therapeutics AB (Nasdaq: CALT, Nasdaq Stockholm: CALTX) (“Calliditas”) today announced that the first patient has been randomized in the company’s pivotal phase 2b/3 TRANSFORM study in patients with primary biliary cholangitis (PBC).The TRANSFORM trial is a 52-week, randomized, placebo-controlled, double-blind, adaptive Phase 2b/3 trial. It will initially investigate the effect of setanaxib 1200 mg/day and 1600 mg/day versus placebo on alkaline phosphatase (ALP) reduction in patients with PBC and with elevated liver stiffness and intolerance or inadequate response to

Dignitana AB appoints Interim CFO

Dignitana AB has appointed Alf Christensson as Interim CFO of Dignitana. He will assume the role on 1 March, 2022. Alf Christensson has most recently been CFO of Salix Group, part of the Swedish industrial group Volati AB, which is listed on Nasdaq Stockholm in the Large Cap segment. He previously served as CFO of Välinge Group and held several leading roles in business and finance with Sony Ericsson. He has a B Sc. In Economics and Management from University of London and lives in Malmö.

SafeTeam wins the procurement – receives large order for digital locks from iLOQ

The security company SafeTeam has received a major order from Ekerö Bostäder after winning a public procurement during the autumn of 2021. The order has a value of just over SEK 5 million and concerns the digital locking system from iLOQ, which will now be installed in the entire Ekerö Bostäder apartment portfolio. The municipality has previously used the system in a limited number of residential buildings, but Ekerö Bostäder has now chosen to extend the system by installing it in all its apartments. Behind the decision was a desire to minimize the harmful impact of lost keys. "

Contract extension for CSV Normand Clipper with Global Marine Group

Solstad Offshore ASA and Global Marine Group have agreed to extend their present contract for the CSV Normand Clipper with further three years to May 2026, and additional options thereafter. Global Marine Group will continue to utilize the vessel to support their world-wide cable lay operations. The commercial terms and conditions are confidential between the parties. Skudeneshavn, February 15[th], 2022 ContactsLars Peder Solstad CEO, at +47 91 31 85 85Kjetil Ramstad CFO, at +47 90 75 94 89 Solstad Offshore ASAwww.solstad.com

Wärtsilä solutions open route to decarbonisation for Poland’s first LNG-fuelled RoPax vessels

Wärtsilä Corporation, Press release, 15 February 2022 at 10.30 AM EETThe technology group Wärtsilä has been contracted by Remontowa shipyard in Poland to supply engines, fuel storage and supply systems for three new RoPax vessels, the first LNG-fuelled RoPax vessels to be built for the Polish maritime sector. The ships will be operated by ferry companies Unity Line and Polferries. The contract with Wärtsilä was signed in January 2022. The vessels will each operate with four highly efficient Wärtsilä 31DF dual-fuel engines . The LNG-fuelled engines can use bio-

New shares of Nurminen Logistics Plc registered with the trade register

Nurminen Logistics Plc                 Stock exchange release February 15, 2022, at 10.30 am A total of 774 386 new shares (the “New Shares”) issued in Nurminen Logistics Plc’s (the “Company”) share issue to the Company itself without consideration has been registered with the Trade Register on February 15, 2022. Following the registration of the New Shares, the total number of the Company’s shares is 77 968 576 shares. The New Shares will be admitted to trading together with the Company’s existing shares on the official list of Nasdaq Helsinki Ltd on or about February 16, 2022.

NOTIFICATION OF MANAGERS’ AND CLOSELY RELATED PARTIES’ TRANSACTIONS WITH DAMPSKIBSSELSKABET NORDEN A/S’ SHARES IN CONNECTION WITH SHARE BUY-BACK PROGRAM

ANNOUNCEMENT NO. 41 - 15 FEBRUARY 2022 In connection with the announced share buy-back program in Dampskibsselskabet NORDEN A/S, A/S Motortramp participates by selling shares pro rata in order to maintain the current ownership of just under 32% of the shares in Dampskibsselskabet NORDEN A/S. The market will be informed accordingly – see the attached file and announcement no. 75/2021. Kind regards, Dampskibsselskabet NORDEN A/S Martin Badsted CFO For further information:Thomas France, Investor Communications Partner, tel.: 3315 0451

SAGA partners with MasterChef Finland

Metsä Tissue’s SAGA brand will be the official partner of MasterChef Finland in the spring of 2022. SAGA, which specialises in biodegradable and compostable paper products for baking and cooking, makes products for both consumer markets and professional kitchens.“Cooperation with the MasterChef programme is ideal for SAGA. The well-known global programme format is all about high quality, and the competitors are supplied with the very best products. Our products meet the criteria of both professionals and demanding home cooks, and it will be exciting to see how the competitors tackle all the

MPC Container Ships joins Mærsk Mc-Kinney Møller Center for Zero Carbon Shipping as an official supporter

MPC Container Ships ASA and Mærsk Mc-Kinney Møller Center for Zero Carbon Shipping have signed a project support agreement making MPC Container Ships ASA an official supporter to the Center. MPC Container Ships ASA will contribute to the Center work with market analysis capabilities building industry insight and strategic industry and policy recommendations focusing on the decarbonization of the maritime sector. MPC Container Ships ASA and its partner companies from the MPC Group are committed to provide further support to the Center hereby using its broad network and expertise in

IMD - Institut für Medizinische Diagnostik launches the GA-map® Microbiome Test in Germany

OSLO, NORWAY/BERLIN, GERMANY – 15 February 2022: Microbiome DX company Genetic Analysis AS (“GA”) and Institut für Medizinische Diagnostik (“IMD”), a part of the Medicover Group, announces today that IMD has launched the GA-map® Dysbiosis Test in Germany. IMD will activate its new Microbiome laboratory in February 2022 and add standardized microbiota testing to its existing test portfolio of products. This new Microbiota test offering will be marketed to customers in Germany and Europe.In 2021, Genetic Analysis launched the updated version of GA-map[®] Dysbiosis Test – the first CE-marked

Exercise of employee share options in Atea ASA ("the Company")

Reference is made to the stock announcement dated 9 February 2022.The share capital increase has been registered by the Norwegian Register ofBusiness Enterprises (Foretaksregisteret), and Atea's Articles of associationhave been revised accordingly.This information is subject of the disclosure requirements acc. to §5-12 vphl(Norwegian Trading Act). For further information, please contact: Robert Giori, CFO Atea ASA, mobile (+47) 934 09 188Ole Johan Fjellestad, Group Chief Accountant Atea ASA, mobile (+47) 992 74 829

There are no items matching the current filter
There are no more items matching the current filter
Back to top